ArticleSurgical endoscopy2025
Short-term outcomes of single-port robotic surgery versus single-port laparoscopic surgery for colon cancer: a multicenter matched-cohort analysis.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Single-port robotic total colectomy: technical standardisation and ergonomic considerations of suprapubic versus periumbilical access.Updates in surgery · 2026Article
- Learning curve for Da Vinci Single-Port robotic colorectal cancer surgery: impact of prior robotic experience.Surgical endoscopy · 2026Article
- Assessing the minimal invasiveness of pure single-incision da Vinci SP surgery for right-sided colon cancer: comparative analysis with the da Vinci Xi system using PSM and IPTW.Surgical endoscopy · 2026Article
- Single-port robotic colorectal surgery: a scoping review of outcome reporting and future directions for standardisation.Journal of robotic surgery · 2026Article
- Comparative perioperative outcomes of single-port laparoscopic ArtiSential versus da Vinci SP platform for totally extraperitoneal inguinal hernia repair: a multi-institutional, propensity score-matched analysis in Korea.Journal of minimally invasive surgery · 2026Article
- Clinical applications of the da Vinci Single-Port robotic system for treatment of colorectal cancer: a narrative review.Annals of surgical treatment and research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSingle-port laparoscopic surgery (SPLS) improves patient comfort; however, it has limitations, including poor instrument triangulation. The da Vinci® SP system used in single-port robotic surgery (SPRS) addresses these challenges. Most studies on SPRS involve small case series or comparisons with multiport procedures, usually lacking direct comparisons with SPLS for colon cancer. Therefore, this study aimed to evaluate the surgical outcomes of SPRS and compare its short-term results with those of SPLS for colon cancer.
methodsThis study included patients who underwent SPRS for colon cancer between March 2019 and April 2023 at four tertiary referral centers. Medical records of these patients were reviewed. Eligible patients were aged 19-85 years, with American Society of Anesthesiologists class I or II, and confirmed adenocarcinoma of the ascending or sigmoid colon without distant metastasis. The data obtained were compared with those of the SPLS cohort from the SIngle-port versus MultiPort Laparoscopic surgEry multicenter randomized trial. A matched cohort analysis accounted for baseline differences.
resultsOverall, 185 and 179 patients were included in the SPRS and SPLS groups, respectively. After matching, 95 and 86 patients who underwent SPRS and SPLS, respectively, were analyzed with balanced baseline characteristics. SPRS was associated with less blood loss, lower conversion rates, fewer intraoperative complications, and faster recovery, including earlier diet resumption and shorter hospital stays, than SPLS.
conclusionsSPRS provides superior perioperative advantages over SPLS, including reduced blood loss, lower conversion rates, fewer complications, and faster recovery. These findings highlight SPRS as a promising option for minimally invasive colorectal surgery, pending further validation to confirm these benefits and ensure long-term efficacy.
Indexed as
Identifiers
41034575What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.